Immediate Release - Liquids and Suspensions

Suspensions are pharmaceutically stable dispersions of an insoluble or sparingly-soluble drug in a liquid vehicle, usually an aqueous solution. They can be ready-to-use or reconstitutable, where the drug is mixed with other ingredients in the dry state and reconstituted with water at the time of dispensing to the patient.

The use of Avicel® RC-591 or CL-611:

  • Maintains suspension uniformity by preventing settling

  • Imparts a thixotropic viscosity profile

  • Increases formulation stability across a wide range of pH

Recommended Products:

Avicel® RC-591

Avicel® CL-611

Viscarin® GP-109, GP-209

 
 
 

Related Applications

Thumb_Excipients_AbuseDeterrence.jpg
  • Abuse Deterrence

Dow’s excipients for drug abuse deterrence applications provide tamper resistant properties.

Thumb_Excipients_APIStability.jpg
  • API Stability

Dow offers solutions to protect APIs from environmental conditions and increase the stability of a drug’s long-term quality, efficacy and safety

yellow_capsules_shutterstock_56239201_3_Card_Layout.png
  • Capsules

Utilizing a novel patented process (alginate) this technology provides a unique seamless, enteric, vegetarian alternative to gelatin soft capsules in one unit process for pharmaceutical and nutraceutical applications.

mother_and_daughter_shutterstock_15995386_3Card_Layout.png
  • Dental Applications

Alginate-based impressions are attractive as orthodontic study models for a variety of reasons. These are fast setting at room temperature, easy to prepare, and very cost effective.

4.2.9_Thumb_enteric_coating.jpg
  • Enteric Coating

Dow’s excipients for the enteric coating of pharmaceutical tablets.

shutterstock_562215688_3_cart_Layout.png
  • Enteric Drug Delivery

An enteric coating resists disintegration in the low pH of the stomach and is dissolved in the neutral pH environment of the intestine

shutterstock_564214432_3_cart_Layout.png
  • Immediate Release – Tablets

Use of Avicel® DG dramatically increases tablet hardness, improves yields and provides good flow and a robust ribbon during the initial compaction phase

shutterstock_373422979.jpg
  • Modified Release

Dow’s excipients for controlled or modified release tablet and capsule formulations.

4.2.10_Thumb_nasal_delivery.jpg
  • Nasal Delivery

Dow’s excipients for the nasal administration of pharmaceuticals.

iStock-582280216.png
  • Organoleptic Enhancements

Chewable tablets as a dosage form are growing in popularity. Palatable chewable tablets offer convenience for customers, broaden the applicability of formulations to pediatric or geriatric markets, and increase patient compliance

Thumb_Excipients_RheologyModifier.jpg
  • Rheology Modifiers

Rheology modifier, dosage form, liquid dosage forms, semi-solid formulations, thickeners, topical applications, thickening agent, Dow, Dow Pharma Solutions, METHOCEL, WALOCEL

Thumb_Excipients_SolubilityEnhancement.jpg
  • Solubility Enhancement

Dow’s portfolio of solubility enhancing excipients for drug compounds with low aqueous solubility.

4.2.3_Thumb_tabelt_coating.jpg
  • Tablet Coating

Dow’s excipients for film tablet coatings are tough, printable, economical and highly consistent.

Thumb_Applications_TasteMasking.jpg
  • Taste-Masking

Dow’s excipients for taste masking applications in the oral drug delivery of tablets.

iStock-467924581.png
  • Topical Preparations

Topical formulations enable local delivery of a drug to a specific site of action without systemic exposure and may be creams, gels, or sprays.

Get Started

DuPont cares about your privacy. Your personal information (name, email, phone number and other contact data) will be stored in chosen customer systems primarily hosted in the United States. This information will be used by DuPont, its affiliates, partners, and selected third parties in other countries to provide you with the product or service information requested. To learn more, please visit www.privacy.dupont.com. By providing your personal information, you agree to the terms and conditions of this Privacy Statement.

 
 
 
/content/dupont/amer/us/en/nutrition-health/references/contact-us.html /content/dupont/amer/us/en/nutrition-health/references/corporate-contact-us.html /content/dupont/amer/us/en/nutrition-health/references/subscribe.html